| scholarly article | Q13442814 |
| P50 | author | Cem Akin | Q42415677 |
| James W Vardiman | Q107318760 | ||
| P2093 | author name string | Lucy A Godley | |
| John Anastasi | |||
| Kelly R Ostler | |||
| Ozden Ozer | |||
| Yi D Zhao | |||
| P2860 | cites work | Activating and dominant inactivating c-KIT catalytic domain mutations in distinct clinical forms of human mastocytosis | Q22001442 |
| One-step detection of c-kit point mutations using peptide nucleic acid-mediated polymerase chain reaction clamping and hybridization probes | Q24685763 | ||
| Crystal structure of human stem cell factor: implication for stem cell factor receptor dimerization and activation | Q27625275 | ||
| Prognostic impact of c-KIT mutations in core binding factor leukemias: an Italian retrospective study | Q27824856 | ||
| Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors | Q28118852 | ||
| Oncogenic kinase signalling | Q28189493 | ||
| The complexity of KIT gene mutations and chromosome rearrangements and their clinical correlation in gastrointestinal stromal (pacemaker cell) tumors | Q28344793 | ||
| pEF-BOS, a powerful mammalian expression vector | Q29547606 | ||
| AML1-ETO and C-KIT mutation/overexpression in t(8;21) leukemia: implication in stepwise leukemogenesis and response to Gleevec. | Q33762738 | ||
| Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder | Q33784323 | ||
| Stem cell factor is encoded at the SI locus of the mouse and is the ligand for the c-kit tyrosine kinase receptor | Q34567286 | ||
| Adverse prognostic significance of KIT mutations in adult acute myeloid leukemia with inv(16) and t(8;21): a Cancer and Leukemia Group B Study | Q34570206 | ||
| Kit and c-kit mutations in mastocytosis: a short overview with special reference to novel molecular and diagnostic concepts. | Q34580164 | ||
| Recent advances in the understanding of mastocytosis: the role of KIT mutations. | Q34635424 | ||
| Mastocytosis: state of the art. | Q34641105 | ||
| W/kit gene required for interstitial cells of Cajal and for intestinal pacemaker activity | Q34719633 | ||
| KIT mutations are common in testicular seminomas | Q35083255 | ||
| Systemic mastocytosis with associated clonal haematological non-mast cell lineage diseases: a histopathological challenge | Q35587647 | ||
| Immunophenotyping of acute leukemias and myelodysplastic syndromes | Q35679885 | ||
| Juxtamembrane autoinhibition in receptor tyrosine kinases. | Q35790329 | ||
| Exon skipping by mutation of an authentic splice site of c-kit gene in W/W mouse | Q35918061 | ||
| Clonality and molecular pathogenesis of mastocytosis. | Q36182758 | ||
| Genetics of myeloid malignancies: pathogenetic and clinical implications | Q36254578 | ||
| Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product | Q38315689 | ||
| Multiple novel alterations in Kit tyrosine kinase in patients with gastrointestinally pronounced systemic mast cell activation disorder | Q40091176 | ||
| Newly identified c-KIT receptor tyrosine kinase ITD in childhood AML induces ligand-independent growth and is responsive to a synergistic effect of imatinib and rapamycin | Q40255904 | ||
| KIT-D816 mutations in AML1-ETO-positive AML are associated with impaired event-free and overall survival | Q40357255 | ||
| Regulation of development, survival and neoplastic growth of mast cells through the c-kit receptor | Q40402590 | ||
| Identification of activating c-kit mutations in adult-, but not in childhood-onset indolent mastocytosis: a possible explanation for divergent clinical behavior | Q40987642 | ||
| Establishment of an immature mast cell line from a patient with mast cell leukemia | Q41296878 | ||
| Inhibition of spontaneous receptor phosphorylation by residues in a putative alpha-helix in the KIT intracellular juxtamembrane region. | Q42471466 | ||
| Apparent KIT Ser(715) deletion in GIST mRNA is not detectable in genomic DNA and represents a previously known splice variant of KIT transcript | Q42855828 | ||
| Systemic mastocytosis with associated clonal hematological non‐mast‐cell lineage disease: Analysis of clinicopathologic features and activating c‐kit mutations | Q43493292 | ||
| Activating mutations of RTK/ras signal transduction pathway in pediatric acute myeloid leukemia | Q44408358 | ||
| A novel form of mastocytosis associated with a transmembrane c-kit mutation and response to imatinib | Q44534510 | ||
| Effects of tyrosine kinase inhibitor STI571 on human mast cells bearing wild-type or mutated c-kit | Q44539087 | ||
| Structural basis for the autoinhibition and STI-571 inhibition of c-Kit tyrosine kinase | Q44881257 | ||
| Mutations in the receptor tyrosine kinase pathway are associated with clinical outcome in patients with acute myeloblastic leukemia harboring t(8;21)(q22;q22). | Q46497558 | ||
| KIT mutations, and not FLT3 internal tandem duplication, are strongly associated with a poor prognosis in pediatric acute myeloid leukemia with t(8;21): a study of the Japanese Childhood AML Cooperative Study Group | Q46807536 | ||
| Cooperating mutations of receptor tyrosine kinases and Ras genes in childhood core-binding factor acute myeloid leukemia and a comparative analysis on paired diagnosis and relapse samples | Q46932369 | ||
| Mutational analysis of the KIT gene in myelodysplastic syndrome (MDS) and MDS-derived leukemia | Q46988174 | ||
| Clinicopathologic, phenotypic, and genotypic characteristics of gastrointestinal mesenchymal tumors | Q47271715 | ||
| Neoplastic mast cells in systemic mastocytosis associated with t(8;21) acute myeloid leukemia are derived from the leukemic clone | Q47592508 | ||
| Incidence and prognostic impact of c-Kit, FLT3, and Ras gene mutations in core binding factor acute myeloid leukemia (CBF-AML). | Q52569827 | ||
| P433 | issue | 8 | |
| P921 | main subject | mast cell | Q191989 |
| P304 | page(s) | 1567-1577 | |
| P577 | publication date | 2008-08-01 | |
| P1433 | published in | Leukemia & Lymphoma | Q6534493 |
| P1476 | title | The identification and characterisation of novel KIT transcripts in aggressive mast cell malignancies and normal CD34+ cells | |
| P478 | volume | 49 |
| Q42908309 | Comparative analysis of mutation of tyrosine kinase kit in mast cells from patients with systemic mast cell activation syndrome and healthy subjects |
| Q38025156 | Diagnosis, progression patterns and prognostication in mastocytosis |
| Q37276382 | KIT GNNK splice variants: expression in systemic mastocytosis and influence on the activating potential of the D816V mutation in mast cells |
Search more.